The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice

European Journal of Pharmacology

Volumn 714, Issue 1-3, 2013, Pages 498-506

  Nikolic, Ivana ^a   Vujicic, Milica ^a   Saksida, Tamara ^a   Berki, Timea ^b   Stosic Grujicic, Stanislava ^a   Stojanovic, Ivana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Diabetes; Glucocorticoids; Inflammation; Insulin; Macrophage migration inhibitory factor

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE TRANSPORTER 2; INSULIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MIFEPRISTONE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HORMONE INHIBITION; HORMONE RELEASE; HYPERGLYCEMIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INSULIN RELEASE; LIVER; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; STEROID RELEASE;

DIABETES; GLUCOCORTICOIDS; INFLAMMATION; INSULIN; MACROPHAGE MIGRATION INHIBITORY FACTOR;

ANIMALS; CORTICOSTERONE; GENE KNOCKOUT TECHNIQUES; GLUCOCORTICOIDS; GLUCOSE; GLUCOSE INTOLERANCE; IMMUNITY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL; MIFEPRISTONE; RECEPTORS, GLUCOCORTICOID;

EID: 84885468620     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.06.037     Document Type: Article

References (33)

1. Berki, T., Pálinkás, L, Boldizsár, F., Németh, P., 2002. Glucocorticoid (GC) sensitivity and GC receptor expression differ in thymocyte subpopulations. Int. Immunol. 14, 463-469. (Pubitemid 34521068)
2. Briassoulis, G., Damjanovic, S., Xekouki, P., Lefebvre, H., Stratakis, CA., 2011. The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic- pituitary-adrenal axis function; implications for pituitary and adrenal tumors. Endocr. Pract. 17, 941-948.
3. Busillo, J.M., Cidlowski, J.A., 2013. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol. Metab. 24, 109-119.
4. Calandra, T., Roger, T., 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800. (Pubitemid 37328657)
5. Chen, F., Zhu, Y, Tang, X., Sun, Y, Jia, W., Sun, Y, Han, X., 2011. Dynamic regulation of PDX-1 and FoxO1 expression by FoxA2 in dexamethasone-induced pancreatic β-cells dysfunction. Endocrinology 152, 1779-1788.
6. Dejager, L, Pinheiro, I., Puimège, L., Fan, Y.D., Gremeaux, L., Vankelecom, H., Libert, C, 2010. Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice. J. Biol. Chem. 285, 31073-31086.
7. Di Dalmazi, G., Pagotto, U., Pasquali, R., Vicennati, V., 2012. Glucocorticoids and type 2 diabetes: from physiology to pathology. J. Nutr. Metab. 2012, 525093.
8. Flaster, H., Bernhagen, J., Calandra, T, Bucala, R., 2007. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol. Endocrinol. 21, 1267-1280. (Pubitemid 46984737)
9. Friedman, J.E., Sun, Y, Ishizuka, T., Farrell, C.J., McCormack, S.E., Herron, LM., Hakimi, P., Lechner, P., Yun, J.S., 1997. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J. Biol. Chem. 272, 31475-31481. (Pubitemid 28013287)
10. Gao, X.M., Liu, Y, White, D., Su, Y, Drew, B.G., Bruce, CR., Kiriazis, H., Xu, Q., Jennings, N., Bobik, A., Febbraio, M.A., Kingwell, B.A., Bucala, R., Fingerle-Rowson, G., Dart, A.M., Morand, E.F., Du, X.J., 2011. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J. Mol. Cell Cardiol. 50, 991-999.
11. Gregory, J.L., Hall, P., Leech, M., Morand, E.F., Hicke, M.J., 2009. Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking. Microcirculation 16, 735-748.
12. Gregory, J.L., Leech, M.T., David, J.R., Yang, Y.H., Dacumos, A., Hickey, M.J., 2004. Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice. Arthritis Rheum. 50, 3023-3034. (Pubitemid 39209542)
13. Gremlich, S., Roduit, R., Thorens, B., 1997. Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids. J. Biol. Chem. 272, 3216-3222.
14. Hoi, A.Y., Iskander, M.N., Morand, E.F., 2007. Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Inflammation Allergy Drug Targets 6, 183-190. (Pubitemid 47455787)
15. Holness, M.J., Smith, N.D., Greenwood, G.K., Sugden, M.C, 2005. Interactive influences of peroxisome proliferator-activated receptor alpha activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. Diabetologia 48, 2062-2068. (Pubitemid 41416917)
16. Liu, Y, Nakagawa, Y, Wang, Y, Sakurai, R., Tripathi, P.V., Lutfy, K., Friedman, T.C, 2005. Increased glucocorticoid receptor and 11{beta}- hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 54, 32-40. (Pubitemid 40105092)
17. Mercado, A.B., Castells, S., 2006. Pancreatic beta-cell hyperactivity in morbidly obese adolescents. Pediatr. Endocrinol. Rev. 3, 560-563. (Pubitemid 46166400)
18. Okada, S., York, D.A., Bray, G.A., 1992. Mifepristone (RU486), a blocker type II glucocorticoid and progestin receptors, reverses a dietary form of obesity. Am. J. Physiol. 262, R1106-R1110.
19. Rafacho A., Marroquí L., Taboga S.R., Abrantes J.L, Silveira L.R., Boschero A.C., Carneiro E.M., Bosqueiro J.R., Nadal A. and Quesada I., Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets, Endocrinology 151, 2010, 85-95.
20. Roger, T., Delaloye, J., Chanson, A.L., Giddey, M., Le Roy, D., Calandra, T., 2013. Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis. J. Infect. Dis. 207, 331-339.
21. Roma, L.P., Oliveira, C.A., Carneiro, E.M., Albuquerque, G.G., Boschero, A.C., Souza, K.L., 2011. N-acetylcysteine protects pancreatic islet against glucocorticoid toxicity. Redox Rep. 16, 173-180.
22. Ruzzin, J., Wagman, A.S., Jensen, J., 2005. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signaling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 48, 2119-2130. (Pubitemid 41416925)
23. Saksida, T., Stosic-Grujicic, S., Timotijevic, G., Sandler, S., Stojanovic, I., 2012. Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis. Immunol. Cell Biol. 90, 688-698.
24. Saksida, T., Stošić-Grujičić, S., Stojanović, I., 2013. The role of macrophage migration inhibitory factor in obesity-associated type 2 diabetes in mice. Arch. Biol. Sci. Belgrade 65, 499-505.
25. Serre-Beinier, V., Toso, C., Morel, P., Gonelle-Gispert, C., Veyrat-Durebex, C., Rohner-Jeanrenaud, F., Calandra, T., Roger, T., James, R.W., Montet, X., Bühler, L., Bosco, D., Berney, T., 2010. Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice. J. Endocrinol. 206, 297-306.
26. Shimomura, Y., Bray, G.A., Lee, M., 1987. Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice. Horm. Metab. Res. 19, 295-299. (Pubitemid 17093215)
27. Short, K.R., Bigelow, M.L., Nair, K.S., 2009. Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy people. Am. J. Physiol. Endocrinol. Metab. 297, E1260-1268.
28. Stojanovic, I., Cvjeticanin, T., Lazaroski, S., Stosic-Grujicic, S., Miljkovic, D., 2009. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology 126, 74-83.
29. Stojanovic, I., Mirkov, I., Kataranovski, M., Glamoclija, J., Stosic-Grujicic, S., 2011. A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus. Immunobiology 216, 1018-1027.
30. Swali, A., Walker, E.A., Lavery, G.G., Tomlinson, J.W., Stewart, P.M., 2008. 11Beta-hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets. Diabetologia 51, 2003-2011.
31. Waeber, G., Calandra, T., Roduit, R., Haefliger, J.A., Bonny, C., Thompson, N., Thorens, B., Temler, E., Meinhardt, A., Bacher, M., Metz, C.N., Nicod, P., Bucala, R., 1997. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 94, 4782-4787. (Pubitemid 27194321)
32. Wang, Y., Nakagawa, Y., Liu, L., Wang, W., Ren, X., Anghel, A., Lutfy, K., Friedman, T.C., Liu, Y., 2011. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia 54, 440-450.
33. Wong, S., Tan, K., Carey, K.T., Fukushima, A., Tiganis, T., Cole, T.J., 2010. Glucocorti-coids stimulate hepatic and renal catecholamine inactivation by direct rapid induction of the dopamine sulfotransferase Sult1d1. Endocrinology 151, 185-194.